The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients. Here, IL18 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.